Metraipolis › archive › dc_b6fe06113cc2

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies — Europe PMC PMID:41479887

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479887
DOI
10.3389/fimmu.2025.1716317
License (as archived)
solo-consultazione
Archived
2026-11-07T14:08:02.053Z
SHA-256 of the archived text
4095b422b115fb4653c8a54440290e7ff45c5de48a26a6b7714d534ed24766d3
Stable URL of this page
https://metraipolis.com/documento/dc_b6fe06113cc2

How to cite

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies — Europe PMC PMID:41479887 — Europe PMC (en), https://europepmc.org/article/MED/41479887 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6fe06113cc2 (Metraipolis archive dc_b6fe06113cc2, sha256 4095b422b115fb4653c8a54440290e7ff45c5de48a26a6b7714d534ed24766d3)
BibTeX
@misc{dcb6fe06113cc2,
  title = {Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies — Europe PMC PMID:41479887},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479887},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6fe06113cc2; sha256 4095b422b115fb4653c8a54440290e7ff45c5de48a26a6b7714d534ed24766d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479887. Agents can read the archived copy with the MCP tool read_document.